SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : FHCI - Future Healthcare

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rory McLeod who wrote (1)7/11/1998 7:04:00 AM
From: Rory McLeod  Read Replies (2) of 6
 
Got this message from O'Brien (reposted with his consent):

this info is pretty old, but very interesting.
post it if you think its helpful

MoFuture Healthcare, Inc. Ticker: FHCI Page 1 of 10
Complete Financials: September 1994 Exchange OTC
FY END DEC
ISSUE DATA (10/10/97) PER SHARE DATA RATIOS
Price $ 0.03 EPS (TTM) $ 0.45 P/E (TTM) 0.07
52W High $ 4.81 Div. Rate $ NA Yield 0.00 %
52W Low $ 0.03 Book Value $ 3.19 Price/Book 0.01
Shrs Out 8.55 Mil Cash $ 0.51 ROE (TTM) 20.69 %
Float 5.60 Mil Rev (TTM) $ 2.26 ROA (TTM) 14.02 %
Mon. Vol 0.00 Mil Curr. Ratio 4.00
Beta NA LT Dbt/Eqty 0.14
BRIEF: Future Healthcare, Inc. provides clinical research
services to the pharmaceutical industry. FHCI contracts to
perform Phase I, II, III, & IV human clinical trials for it
clients. FHCI owns and operates 10 clinics. For the 9 mos.
ended 9/94, revenues rose from $7M to $14.4M. Net income
rose from $1.2M to $3M. Results reflect Co.'s ability to
acquire and perform a higher number of study contracts, &
new clinics opened & acq'd in FL, TX, CA & OR.

Copyright (c) 1997, Market Guide Inc., All rights reserved (more)

MoFuture Healthcare, Inc. QUARTERLY SUMMARY Page 2 of 10
HISTORICAL QUARTERLY RESULTS(Thousands of U.S. Dollars)
REVENUE 1991 1992 1993 1994
1st Qtr MAR 0 993 1,919 3,801
2nd Qtr JUN 608 1,167 2,391 4,705
3rd Qtr SEP 219 1,356 2,722 5,887
4th Qtr DEC 622 1,450 3,237
EPS (U.S. Dollars per share)
1st Qtr MAR 0.000 0.000 0.020 0.100
2nd Qtr JUN -0.380 0.030 0.030 0.120
3rd Qtr SEP -0.270 0.010 0.150 0.150
4th Qtr DEC -0.200 0.070 0.090

All EPS prior to IPO is pro forma. FY'92 & FY'91 EPS
reflects a rise in weighted avg. shares o/s. 6/91 Q. = 6
months. 5/95, Co. delisted to Pinks. 3/92, cash flow NA.

DIVIDENDS EMPLOYEES
Last Dividend Decl. $ NA # Employees 111
Last Div Ex-Date NA Sales/Employee (TTM) 158,829
Last Div Pay Date NA Net. Income/Empl.(TTM) 32,595
Copyright (c) 1997, Market Guide Inc., All rights reserved (more)

MoFuture Healthcare, Inc. COMPANY COMPARISON Page 3 of 10
TO THE BIOTECHNOLOGY AND S&P 500 AGGREGATES
VALUATION RATIOS: COMPANY INDUSTRY S&P 500
P/E Ratio 0.07 43.81 26.45
Dividend Yield 0.00 0.01 1.56
Price to Tangible Book 0.01 8.87 8.15
Price to Book 0.01 8.19 6.14
Price to Free Cash Flow -0.03 39.04 38.27
GROWTH STATISTICS:
3 Yr Rev Growth 111.01 36.66 13.65
3 Yr EPS Growth NM 19.51 21.01
3 Yr Div Growth NM 4.77 10.78
Reinvestment Rate 100.00 99.82 67.68
PROFITABILITY RATIOS:
Net Profit Margin 20.52 7.34 10.33
Return on Equity 20.69 -2.66 22.56
Interest Coverage 15.62 4.13 10.16
FINANCIAL STRENGTH RATIOS:
Current Ratio 4.00 6.24 1.51
LT Debt to Equity 0.14 0.20 0.75
Total Debt to Equity 0.24 0.23 1.03
Copyright (c) 1997, Market Guide Inc., All rights reserved (more)

MoFuture Healthcare, Inc. TRADING & PRICE PERFORMANCE Page 4 of 10
INSTITUTIONAL OWNERSHIP INSIDER TRADING (Prev. 6 months)
% Shares Out. Owned 3.01 % Net Insider Trades 0
# of Institutions 8 # Buy Transactions 0
Total Shs Held 0.257 Mil # Sell Transactions 0
3 Mo. Net Purch. 0.008 Mil Net Shares Bought 0.000 Mil
3 Mo. Shs Purch. 0.015 Mil # Shares Bought 0.000 Mil
3 Mo. Shs Sold 0.007 Mil # Shares Sold 0.000 Mil

4 Week Price % Change NA% 4 Week Rel. Price % Change NA%
13 Week Price % Change NA% 13 Week Rel. Price % Change NA%
26 Week Price % Change NA% 26 Week Rel. Price % Change NA%
52 Week Price % Change NA% 52 Week Rel. Price % Change NA%
YTD Week Price % Change NA% YTD Week Rel. Price % Change NA%

MARKET MAKERS: WDCO JOSE HRZG KEMP TSCO

Copyright (c) 1997, Market Guide Inc., All rights reserved (more)

MoFuture Healthcare, Inc. EQUITY, OFFICERS & ADDRESS Page 5 of 10
Common Stock no par, 11/94, 10M auth., 8,549,855 issued.
Insiders own approx. 26%. James W. Harpel owns approx. 9%.
IPO 10/92, 600K shares @ $4.50 by Glaser Capital Corp. P/O:
1/94, 1.36M (800K by Co.) @ $12.25 by Glaser Capital. STD:
$1.3M @ Prime + 1%; LTD: $5.2M @ 5.5%, $340K @ 9% - 12%,
$551K in capital leases. 12/93, 2-for-1 stock split.

OFFICERS: John D. Peckskamp, Jr., Chmn./CEO, Donna J.
Myers, Pres., Keith A. Cheeseman, CFO, Douglas Coates,
VP-Fin./Cntrlr./Secy. TRANSFER AGENT: Huntington National
Bank. Company incorporated 1985 in OH. Direct inquiries
to: Donna J. Myers, President.
ADDRESS & PHONE NUMBERS
Future Healthcare, Inc.
201 East Fourth Street
19th Floor
Cincinnati, OH 45202
PHONE: (513) 651-2525
FAX: (513) 784-1642

Copyright (c) 1997, Market Guide Inc., All rights reserved (more)

MoFuture Healthcare, Inc. ANNUAL INCOME STATEMENT Page 6 of 10
(Thousands of U.S. Dollars)
12M 12/31/90 12M 12/31/91 12M 12/31/92 12M 12/31/93
Contract Revenues 1,093 1,449 4,966 10,269
Total Revenue 1,093 1,449 4,966 10,269
Cost of Revenues 1,581 2,220 3,252 6,667
Sell./Gen./Admin. 720 1,207 936 1,947
Total Expenses 2,301 3,427 4,188 8,614
Operating Income -1,208 -1,978 778 1,655

Copyright (c) 1997, Market Guide Inc., All rights reserved (more)

MoFuture Healthcare, Inc. ANNUAL INCOME STATEMENT Page 7 of 10
(Thousands of U.S. Dollars)
12M 12/31/90 12M 12/31/91 12M 12/31/92 12M 12/31/93
Operating Income -1,208 -1,978 778 1,655
Interest Expense -91 -207 -189 -339
Other, Net -56 -50 -183 -52
Income Before Taxes -1,355 -2,235 406 1,264
Income Taxes 0 0 0 -556
Income After Taxes -1,355 -2,235 406 1,820
Pro Forma Adjustment 64 64 0 0
EPS Excl. XOrd Items -0.645 -0.851 0.109 0.291
EPS Incl. XOrd Items -0.645 -0.851 0.109 0.291
Avg Primary Shs Out. 2,003.06 2,551.50 3,710.46 6,257.55
Common Dividends/Shr 0.0000 0.0000 0.0000 0.0000

Copyright (c) 1997, Market Guide Inc., All rights reserved (more)

MoFuture Healthcare, Inc. SELECTED INCOME STATEMENT Page 8 of 10
(Thousands of U.S. Dollars)
QUARTERS YEAR TO DATE
3M 09/30/93 3M 09/30/94 9M 09/30/93 9M 09/30/94
Revenue 2,722 5,887 7,032 14,393
Operating Expenses 2,216 3,904 6,143 9,771
Operating Income 506 1,983 889 4,622
Non-Operating Income 0 65 0 194
Non-Operating Expenses -122 -88 -201 -207
Income Before Taxes 384 1,960 688 4,609
Income Taxes -556 653 -556 1,567
Adjustments to Income 0 0 0 0
Inc. for Primary EPS 940 1,307 1,244 3,042
EPS Excl. Xord Items 0.146 0.149 0.196 0.365
Disc Opns + Xord Items 0 0 0 0
EPS Incl. Xord Items 0.146 0.149 0.196 0.365
Avg Primary Shs Out. 6,428.63 8,774.56 6,184.08 8,256.13
F.D. EPS Excl. Xord 0.146 0.149 0.196 0.365
F.D. EPS Incl. Xord 0.146 0.149 0.196 0.365
Common Dividends/Shr 0.000 0.000 0.000 0.000

Copyright (c) 1997, Market Guide Inc., All rights reserved (more)

MoFuture Healthcare, Inc. SELECTED BALANCE SHEET Page 9 of 10
(Thousands of U.S. Dollars)
YEAR ENDING QUARTER ENDING
12/31/92 12/31/93 09/30/93 09/30/94
Cash & ST Investments 706 1,159 2,977 4,294
Receivables 3,214 9,280 6,358 4,978
Total Current Assets 5,234 12,805 12,009 24,347
LT Investments 0 0 0 0
Fixed Assets 522 2,397 1,059 4,574
Total Assets 6,000 17,921 14,801 36,900
Accounts Payable 585 815 389 618
ST Debt & Curr LTD 672 1,621 1,062 2,718
Total Current Liab. 1,887 4,194 2,188 6,089
LT Debt & Cap Leases 339 5,781 6,405 3,670
Total Liabilities 2,226 9,975 8,593 9,759
Preferred Stock 0 0 0 0
Common/Paid In Capital 8,815 11,344 9,915 29,280
Retained Earnings -5,042 -3,222 -3,707 -184
Total Equity 3,773 7,947 6,208 27,142
Shares Outstanding 5,477 6,336 6,177 8,499

Copyright (c) 1997, Market Guide Inc., All rights reserved (more)

MoFuture Healthcare, Inc. SELECTED STMT OF CASH FLOWS Page 10 of 10
INDIRECT METHOD (Thousands of U.S. Dollars)
ANNUAL YEAR TO DATE
12M 12/31/92 12M 12/31/93 9M 09/30/93 9M 09/30/94
Net Income 406 1,820 0 0
Depreciation & Amort. 166 350 0 0
Non Cash Items 11 -74 0 0
Total Operating CF -3,557 -4,933 -3,338 -2,112
Capital Expenditures -380 -1,705 -638 -3,449
Total Investing CF -380 -1,088 -288 -5,114
Dividends Paid 0 0 0 0
Sale (Purch.) of Stock 4,554 365 108 10,320
Net Borrowings 17 6,157 5,789 41
Total Financing CF 4,571 6,472 5,897 10,361
Exchange Rate Effect 0 0 0 0
Net Change In Cash 633 453 2,272 3,135
Oper CF-Cap Exp-Div Pd -3,937 -6,638 -3,976 -5,561

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext